As of 2024-12-12, the Intrinsic Value of Syndax Pharmaceuticals Inc (SNDX) is
-17.40 USD. This SNDX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 14.23 USD, the upside of Syndax Pharmaceuticals Inc is
-222.28%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-17.40 USD
Intrinsic Value
SNDX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-17.40 - -17.40 |
-17.40 |
-222.28% |
| P/E |
(97.93) - (108.79) |
(96.05) |
-775.0% |
| DDM - Stable |
(27.70) - (108.14) |
(67.92) |
-577.3% |
| DDM - Multi |
(0.32) - (0.94) |
(0.48) |
-103.3% |
SNDX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,214.67 |
| Beta |
2.07 |
| Outstanding shares (mil) |
85.36 |
| Enterprise Value (mil) |
1,081.67 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.85% |
| Cost of Debt |
5.00% |
| WACC |
9.85% |